BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23182790)

  • 1. [Illegal abortion with misoprostol in Guadeloupe].
    Manouana M; Kadhel P; Koffi A; Janky E
    J Gynecol Obstet Biol Reprod (Paris); 2013 Apr; 42(2):137-42. PubMed ID: 23182790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A six month prospective study on different aspects of abortion.
    Madebo T; G/Tsadic T
    Ethiop Med J; 1993 Jul; 31(3):165-72. PubMed ID: 8404881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy.
    Gonzalez CH; Marques-Dias MJ; Kim CA; Sugayama SM; Da Paz JA; Huson SM; Holmes LB
    Lancet; 1998 May; 351(9116):1624-7. PubMed ID: 9620717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home self-administration of vaginal misoprostol for medical abortion at 50-63 days compared with gestation of below 50 days.
    Kopp Kallner H; Fiala C; Stephansson O; Gemzell-Danielsson K
    Hum Reprod; 2010 May; 25(5):1153-7. PubMed ID: 20172871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Commercial availability of misoprostol and induced abortion in Brazil.
    Costa SH
    Int J Gynaecol Obstet; 1998 Dec; 63 Suppl 1():S131-9. PubMed ID: 10075223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective survey of cases of complications of induced abortion presenting to Goroka Hospital, Papua New Guinea, 2011.
    Asa I; de Costa C; Mola G
    Aust N Z J Obstet Gynaecol; 2012 Oct; 52(5):491-3. PubMed ID: 22694099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal morbidity and outcome of live born premature babies after attempted illegal abortion with misoprostol.
    Escumalha M; Gouveia C; Cunha M; Vale F; Machado MC
    Pediatr Nurs; 2005; 31(3):228-31. PubMed ID: 16060589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion.
    Mittal S; Agarwal S; Kumar S; Batra A
    Indian J Med Res; 2005 Aug; 122(2):132-6. PubMed ID: 16177470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of illegal abortions in Libreville Hospital, Gabon].
    Mayi-Tsonga S; Diallo T; Litochenko O; Methogo M; Ndombi I
    Bull Soc Pathol Exot; 2009 Oct; 102(4):230-2. PubMed ID: 19950540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motivations for using misoprostol for abortion outside the formal healthcare system in Colombia: a qualitative study of women seeking postabortion care in Bogotá and the Coffee Axis.
    Ortiz J; Blades N; Prada E
    Reprod Health; 2024 Jun; 21(1):76. PubMed ID: 38824533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
    Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
    Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized trial of oral versus sublingual misoprostol 24 h after mifepristone for medical abortion.
    Dahiya K; Mann S; Nanda S
    Arch Gynecol Obstet; 2011 Jul; 284(1):59-63. PubMed ID: 20652288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misoprostol and illegal abortion in Fortaleza, Brazil.
    Coêlho HL; Teixeira AC; Santos AP; Forte EB; Morais SM; La Vecchia C; Tognoni G; Herxheimer A
    Lancet; 1993 May; 341(8855):1261-3. PubMed ID: 8098403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and clinical correlates of unsuccessful use of drugs to induce menstruation.
    Mengue SS; Schenkel EP; Duncan BB; Schmidt MI
    Contraception; 1998 Feb; 57(2):93-7. PubMed ID: 9589835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion.
    Kopp Kallner H; Fiala C; Gemzell-Danielsson K
    Contraception; 2012 Apr; 85(4):394-7. PubMed ID: 22067756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
    Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
    Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The knowledge, acceptability, and use of misoprostol for self-induced medical abortion in an urban US population.
    Rosing MA; Archbald CD
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):183-5. PubMed ID: 10846334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abortion failure after illegal use of misoprostol--a case report.
    Rouzi AA
    Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):376-8. PubMed ID: 20863260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol.
    Vitner D; Deutsch M; Paz Y; Khatib N; Baltiter T; Rosenberg S; Lowenstein L
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):140-3. PubMed ID: 21507550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.